Clinical Trial Update: Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sirolimus-eluting stents to intravascular brachytherapy for in-stent restenosis has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• In-stent Restenosis

Drugs mentioned

• Intravascular brachytherapy (intravascular brachytherapy)
• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: In-Stent Restenosis | Phase 3 | Status: COMPLETED